omeprazole has been researched along with n 0437, (-)-isomer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreas, JO; Braun, M; Cawello, W; Elshoff, JP | 1 |
1 other study(ies) available for omeprazole and n 0437, (-)-isomer
Article | Year |
---|---|
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Area Under Curve; Biotransformation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Dopamine Agonists; Drug Interactions; Genotype; Healthy Volunteers; Humans; Male; Middle Aged; Omeprazole; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Proton Pump Inhibitors; South Africa; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Young Adult | 2014 |